HIFα Stabilization for Selective Visceral Fat Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively regulate fat metabolism and body weight, leading to obesity and associated health issues such as diabetes and cardiovascular disease, as they do not adequately address the stabilization of HIFα, a key factor in fat regulation.
Innovation Solution
The stabilization of HIFα is achieved by inhibiting HIF hydroxylase activity using compounds that interact with HIFα or its interacting factors, such as EGLN1, EGLN2, and EGLN3, thereby regulating fat metabolism processes like uptake, storage, and synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional methods are used to regulate fat metabolism, then general fat reduction may be achieved, but selective reduction of visceral fat without muscle loss cannot be achieved
Solution Approach 1:
The invention changes the molecular parameter by stabilizing HIFα at the post-translational level through inhibition of prolyl hydroxylase enzymes (EGLN1, EGLN2, EGLN3). This parameter change in HIFα stability selectively activates genes that promote visceral fat breakdown and inhibit adipogenesis, while preserving muscle mass, achieving selective fat reduction that conventional methods cannot accomplish
Solution Approach 2:
The invention introduces HIFα as an intermediary molecule that mediates the effect of hydroxylase inhibitors on fat metabolism. By stabilizing HIFα, the compound indirectly regulates multiple downstream targets including lipolysis enzymes, adipogenic transcription factors, and muscle protein synthesis pathways, achieving coordinated selective fat reduction with muscle preservation
2Reliability
If HIFα stabilization is achieved through hydroxylase inhibition, then fat metabolism regulation is improved, but the complexity of the molecular pathway increases
Solution Approach 1:
The invention performs preliminary action by stabilizing HIFα upstream in the metabolic pathway before it can be degraded by hydroxylases. This preliminary stabilization of the key regulator HIFα allows downstream effects to occur naturally through existing cellular machinery, reducing the need for additional complex molecular components while achieving reliable fat metabolism regulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces body fat, particularly visceral fat, induces weight loss without muscle loss, and treats or prevents obesity and related metabolic disorders by promoting fat utilization as an energy source, thereby improving metabolic health.
Implementation Method 1
HIFα is degraded under normoxic, i.e., normal oxygen conditions, and is stabilized under hypoxic, i.e., low oxygen conditions. Upon stabilization, HIFα combines with HIFβ to produce a number of downstream effects. It was recently determined that hydroxylation of particular residues on the HIFα subunit targeted HIFα for degradation
Implementation Method 2
HIFα is a transcription factor that regulates gene expression in response to oxygen levels. Under hypoxic conditions, HIFα is not hydroxylated and remains stable, translocating to the nucleus where it dimerizes with HIFβ to regulate target gene expression
Data Source
AI summary
The present invention provides methods and compounds for regulating fat metabolism and achieving fat homoeostasis in a subject. Methods and compound for regulating body weight, reducing body fat, and inducing weight loss are also provided, as are methods and compounds for treating or preventing obesity and for preventing or treating conditions associated with altered fat metabolism including, e.g., obesity, diabetes, atherosclerosis, etc.